Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Amgen (AMGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 118,044,120
  • Shares Outstanding, K 735,890
  • Annual Sales, $ 22,991 M
  • Annual Income, $ 7,722 M
  • 36-Month Beta 1.26
  • Price/Sales 5.19
  • Price/Cash Flow 11.07
  • Price/Book 4.03

Price Performance

See More
Period Period Low Period High Performance
1-Month
160.25 +1.80%
on 04/21/17
166.61 -2.08%
on 03/27/17
-2.60 (-1.57%)
since 03/24/17
3-Month
151.77 +7.49%
on 01/25/17
184.21 -11.44%
on 03/15/17
+11.29 (+7.43%)
since 01/24/17
52-Week
133.64 +22.07%
on 11/04/16
184.21 -11.44%
on 03/15/17
-0.05 (-0.03%)
since 04/22/16

Most Recent Stories

More News
Novartis expands global collaboration with Amgen to commercialize first-in-class AMG 334 (erenumab) program in migraine prevention in the U.S. and Canada

Novartis today announced an expanded commercialization agreement with Amgen for AMG 334 (erenumab), which is being investigated for the prevention of migraine. This agreement builds on a 2015 global collaboration...

NVS : 74.61 (+1.65%)
AMGN : 163.14 (+1.70%)
Celgene (CELG) to Post Q1 Earnings: What's in the Cards?

Celgene Corporation (CELG) is scheduled to report first-quarter 2017 results on Apr 27, before the opening bell.

CELG : 123.15 (+0.73%)
GILD : 66.25 (+0.49%)
ICPT : 111.11 (+2.98%)
AMGN : 163.14 (+1.70%)
Is Pain Ahead for Healthcare ETFs After Weak JNJ Q1?

Results from Johnson and Johnson could be a warning sign for other drug makers, which are scheduled to report this week and the next.

VHT : 137.82 (+0.96%)
JNJ : 122.89 (+0.93%)
MRK : 62.14 (+0.40%)
IYH : 156.20 (+0.96%)
FHLC : 35.80 (+0.96%)
ABBV : 64.66 (+1.32%)
AMG : 166.45 (+1.92%)
GILD : 66.25 (+0.49%)
SPY : 237.17 (+1.10%)
AMGN : 163.14 (+1.70%)
PFE : 33.74 (+0.30%)
BMY : 53.55 (+0.13%)
What's in Store for Agenus (AGEN) this Earnings Season?

Agenus Inc. (AGEN) is expected to report first-quarter 2017 results later this month or early next month.

AGEN : 3.60 (+2.27%)
MRK : 62.14 (+0.40%)
GILD : 66.25 (+0.49%)
AMGN : 163.14 (+1.70%)
Is Pain Ahead for Healthcare ETFs After Weak JNJ Q1?

Results from Johnson and Johnson could be a warning sign for other drug makers, which are scheduled to report this week and the next.

VHT : 137.82 (+0.96%)
JNJ : 122.89 (+0.93%)
MRK : 62.14 (+0.40%)
IYH : 156.20 (+0.96%)
FHLC : 35.80 (+0.96%)
ABBV : 64.66 (+1.32%)
AMG : 166.45 (+1.92%)
GILD : 66.25 (+0.49%)
SPY : 237.17 (+1.10%)
AMGN : 163.14 (+1.70%)
PFE : 33.74 (+0.30%)
BMY : 53.55 (+0.13%)
Amgen (AMGN) to Report Q1 Earnings: Will it Beat Again?

We expect biotech major Amgen Inc. (AMGN) to beat expectations when it reports first-quarter 2017 results on Apr 26 after the market closes.

CLDX : 3.22 (+0.62%)
GILD : 66.25 (+0.49%)
ICPT : 111.11 (+2.98%)
AMGN : 163.14 (+1.70%)
Alexion (ALXN) Q1 Earnings: Can the Stock Pull a Surprise?

Alexion Pharmaceuticals, Inc. (ALXN) is scheduled to report first quarter 2017 results on Apr 27, before the opening bell.

GILD : 66.25 (+0.49%)
ICPT : 111.11 (+2.98%)
AMGN : 163.14 (+1.70%)
ALXN : 119.54 (+2.33%)
Universal Health (UHS) Q1 Earnings: What's in the Cards?

Universal Health Services, Inc (UHS) is set to report first-quarter 2017 results on Apr 25, after the market closes.

HUM : 213.76 (+0.04%)
UHS : 120.90 (+1.73%)
ANTM : 168.41 (+0.36%)
AMGN : 163.14 (+1.70%)
Eli Lilly (LLY) to Report Q1 Earnings: What's in the Cards?

Eli Lilly and Company (LLY) will report first-quarter 2017 results on Apr 25, before the market opens.

CLDX : 3.22 (+0.62%)
LLY : 83.42 (+1.87%)
AMGN : 163.14 (+1.70%)
SNY : 45.90 (+4.11%)
Novartis (NVS) Q1 Earnings: Will the Stock Disappoint?

Swiss pharmaceutical company Novartis AG (NVS) is scheduled to report first-quarter 2017 results on Apr 25.

NVS : 74.61 (+1.65%)
GILD : 66.25 (+0.49%)
ICPT : 111.11 (+2.98%)
AMGN : 163.14 (+1.70%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Amgen Inc. discovers, develops and delivers innovative human therapeutics. A biotechnology pioneer, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice...

See More

Support & Resistance

2nd Resistance Point 164.58
1st Resistance Point 163.86
Last Price 163.14
1st Support Level 162.16
2nd Support Level 161.18

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.